Initially, the CAD risk associated with 9p21.3 genetic variants and ANRIL expression was reported being independent of traditional CAD risk factors like sex, smoking, obesity, hypertension, or diabetes [15,16,17]. This evidence concerns the gene CDKN2B-AS1 and obesity disorder.